Drug
Activated Recombinant Human Factor Vii
Activated Recombinant Human Factor Vii: highest development phase Phase 2, developed by Novo Nordisk. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Novo Nordisk
Trials
| Drug | Phase | Indication |
|---|---|---|
| activated recombinant human factor VII NCT00426803 | Phase 2 | Acquired Bleeding Disorder |
Latest
No recent events.
Follow Activated Recombinant Human Factor Vii on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.